RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E

Watchlist Manager
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS Logo
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
Watchlist
Price: 3.6 TRY 0.28% Market Closed
Market Cap: 1.8B TRY

Intrinsic Value

The intrinsic value of one RTALB.E stock under the Base Case scenario is 2.22 TRY. Compared to the current market price of 3.6 TRY, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS is Overvalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RTALB.E Intrinsic Value
2.22 TRY
Overvaluation 38%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS

What is Valuation History?
Ask AI Assistant
What other research platforms think about RTALB.E?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is RTALB.E valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS.

Explain Valuation
Compare RTALB.E to

Fundamental Analysis

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
TR
Biotechnology
Market Cap
1.8B TRY
IPO
Jun 2, 2014
TR
Biotechnology
Market Cap
1.8B TRY
IPO
Jun 2, 2014
Price
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RTALB.E?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS

Current Assets 172.9m
Cash & Short-Term Investments 9.6m
Receivables 88.3m
Other Current Assets 75m
Non-Current Assets 2.1B
Long-Term Investments 1.7B
PP&E 327.3m
Intangibles 27.8k
Other Non-Current Assets 64.1m
Current Liabilities 77.2m
Accounts Payable 24.3m
Accrued Liabilities 7.4m
Short-Term Debt 18.9m
Other Current Liabilities 26.7m
Non-Current Liabilities 26.3m
Long-Term Debt 21.6m
Other Non-Current Liabilities 4.7m
Efficiency

Free Cash Flow Analysis
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS

Revenue
185.9m TRY
Cost of Revenue
-124.2m TRY
Gross Profit
61.8m TRY
Operating Expenses
-126.7m TRY
Operating Income
-64.9m TRY
Other Expenses
295.9m TRY
Net Income
231m TRY
Fundamental Scores

RTALB.E Profitability Score
Profitability Due Diligence

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Exceptional Net Margin
Strong 3Y Average Net Margin
Positive 3Y Average ROE
Healthy Gross Margin
43/100
Profitability
Score

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

RTALB.E Solvency Score
Solvency Due Diligence

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
60/100
Solvency
Score

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RTALB.E Price Targets Summary
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS

There are no price targets for RTALB.E.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
does not pay dividends
Shareholder Yield

Current shareholder yield for RTALB.E is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one RTALB.E stock?

The intrinsic value of one RTALB.E stock under the Base Case scenario is 2.22 TRY.

Is RTALB.E stock undervalued or overvalued?

Compared to the current market price of 3.6 TRY, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS is Overvalued by 38%.

Back to Top